Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
10/2004
10/20/2004CN1171846C Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
10/19/2004US6806366 Such as 2-((4-(4-(4-(bis-carbamoylmethyl-sulfamoyl)-benzyl) -6-chloro-(1,3,5)triazin-2-ylmethyl)-benzenesulfonyl)-carbamoyl methyl-amino)acetamide; precipitation; crystallization
10/19/2004US6806357 Fluorous nucleophilic substitution of alcohols and reagents for use therein
10/19/2004US6806291 2-(((4-hydroxyphenyl)carbamoyl)alkylsulfamoyl)benzoic acids; limited hepatotoxic effect
10/14/2004WO2004087881A2 Process for preparing reverse transcriptase inhibitors
10/14/2004WO2004087623A2 An improved process for the preparation of (r) (-) tamsulosin hydrochloride
10/14/2004WO2004087057A2 Methods for inhibition of angiogenesis
10/14/2004WO2004071401A3 Hydroxamic acid derivatives as histone deacetylase inhibitors (hdca)
10/14/2004WO2004000781A3 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
10/14/2004WO2004000762A3 Propionic acid derivatives and their use as hppars activators
10/14/2004US20040204599 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/14/2004US20040204412 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer
10/13/2004EP1466898A1 Beta-amyloid protein production/secretion inhibitors
10/13/2004EP1466896A1 Process for producing crystal of benzenesulfonamide derivative, and novel crystal of intermediate therefor and process for producing the same
10/13/2004EP1466891A1 Carboxylic acid derivative
10/13/2004EP1466625A1 Preventives/remedies for urinary disturbance
10/13/2004EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
10/13/2004CN1537088A Transfer hydrogenation process and catalyst
10/12/2004US6803484 Sulfonamide derivatives
10/12/2004US6803384 Diaminopropionic acid derivatives
10/12/2004US6803378 For therapy and prophylaxis of acquired immune deficiency syndrome (aids), or arc
10/12/2004CA2170394C Process for conditioning substances
10/07/2004WO2004084898A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
10/07/2004WO2004043911A3 N-cycloalkylglycines as hiv protease inhibitors
10/07/2004US20040199011 Phosgenation of 2-trifluoromethylbenzenesulfonamide in the presence of sodium benzenesulfonate and butyl isocyanate to form 2-trifluoromethylbenzenesulfonyl isocyanate; by product inhibition; efficiency
10/07/2004US20040198833 Acetylenic sulfonamide derivatives
10/07/2004US20040198777 obesity; antidiabetic agents; Alzheimer's disease; Huntington's disease;schizophrenia; antiproliferative agents; anticancer agents; antiepileptic agents; deafness
10/06/2004EP1463715A1 Novel glucagon antagonists
10/06/2004EP1463714A2 Vanilloid receptor ligands and their use in treatments
10/06/2004EP1463707A2 A group of novel anti-cancer compounds with specific structure
10/06/2004EP1463502A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
10/06/2004EP1210325B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
10/06/2004EP1101755B1 Anthranilic acid derivatives
10/06/2004CN1535486A Novel onium salt, electrolyte for nonaqueous cell containing novel onium salt for nonaqueous cell, and method for optimizing negative electrode using electrolyte containing onium salt
10/06/2004CN1535151A Novel anti-infectives
10/05/2004US6800097 For dyeing keratin fibers; hair dyes
09/2004
09/30/2004WO2004083867A2 Modulators of g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders
09/30/2004WO2004058683A3 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
09/30/2004WO2003072535A8 Substituted hydroxyethylamines
09/30/2004US20040192910 Controlling weeds; applying to plants; preemergence or postemergence herbicide
09/30/2004US20040192731 For agriculture crops
09/30/2004US20040192710 Such as trans-4-amino-3,4-dihydro-2,2-dimethyl-6-cyano-2H-benzopyran; for use as antiarrhythmic agents
09/30/2004US20040192681 N-acylsulfonamide apoptosis promoters
09/30/2004CA2519230A1 Modulators of the g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders
09/29/2004EP1461313A1 Human adam-10 inhibitors
09/29/2004EP1461038A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
09/29/2004EP1100483B1 Glucocorticoid-selective anti-inflammatory agents
09/29/2004CN1533400A Probes, system and methods for drug discovery
09/28/2004US6797731 Resorcinol derivatives
09/28/2004US6797707 Therapeutic treatment of opiate and nicotine addiction, drug dependence, and tolerance; a polypeptide derivatives having n-terminal 5-(dimethylamino)-1-naphthalenesulfonyl group, c-terminal arginine- amide group
09/28/2004CA2299013C Neuropeptide y antagonists
09/23/2004WO2004080974A1 A purification method of ionic liquids to obtain their high purity
09/23/2004WO2004080952A1 Phenylsulfonamide derivatives for treating alzheimer's disease
09/23/2004WO2004080951A2 Sulfonic acids, their derivatives and pharmaceutical compositions containing them
09/23/2004WO2004080389A2 Hydroxyeicosadienamide compounds
09/23/2004US20040186176 method of treating multi-drug resistant mycobacteria especially corynebacteria, nocardiae, rhodococcus, and mycobacteria
09/23/2004US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
09/23/2004DE10341535A1 New N,N-disubstituted (hetero)arylsulfonamide derivatives are gamma-secretase inhibitors useful for treatment or prophylaxis of Alzheimer's disease
09/23/2004CA2514988A1 Sulfonic acids, their derivatives and pharmaceutical compositions containing them
09/22/2004EP1458676A2 Compounds for the treatment of inflammatory disorders
09/22/2004EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase
09/22/2004EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/22/2004EP1124820B1 Lipoic acid derivatives and their use in treatment of disease
09/22/2004CN1531425A Urea derivatives as integrin alpha 4 antagonists
09/21/2004US6794511 An enzyme inhibitors of metalloprotease; treating connective tissue degradation caused by inflammation or tumor
09/21/2004CA2155843C Novel urea derivatives, their preparation and use
09/16/2004WO2004078769A1 Process for the preparation of anticonvulsant derivatives of topiramate
09/16/2004WO2004078144A2 Diphenylethylene compounds and uses thereof
09/16/2004WO2004069782A3 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
09/16/2004WO2003091207A3 Method of preparing amine stereoisomers
09/16/2004US20040181094 Reaction of alkyne and nucleophile in the presence of Ruthenium oxo catalysts with displacement for synthesis of propargylamine or propargyl ethers
09/16/2004US20040181065 Process for preparing 2-amino-4-(4-fluorphenyl) -6-alkylpyrimidine-5-carboxylate
09/16/2004US20040180964 anti-obestic activity; Neuropeptide Y antagonist
09/16/2004US20040180939 Acetyl 2-hydroxy-1, 3-diaminoalkanes
09/16/2004US20040180892 control of cardiovascular homeostasis is achieved through a combination of both direct neuronal control and systemic neurohormonal activation
09/16/2004US20040180876 Selective beta 2-adrenoreceptor agonists; rapid onset of action, long duration; such as 3-(4-{[6-{(-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide; synthesis
09/16/2004US20040180871 Anti-inflammatory compositions and methods
09/16/2004CA2517964A1 Process for the preparation of anticonvulsant derivatives of topiramate
09/16/2004CA2517886A1 Diphenylethylene compounds and uses thereof
09/15/2004EP1457485A1 Sulfonic acids, their derivatives and pharmaceutical compositions containing them
09/15/2004EP1456171A1 Substituted cyclohexane derivatives
09/15/2004EP1455777A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
09/15/2004EP1455773A1 2-aryl-propionic acids and pharmaceutical compositions containing them
09/15/2004EP1455747A1 Skin lightening agents, novel compounds, compositions and use
09/15/2004EP1140515B1 Heat sensitive recording material
09/15/2004EP1077925B1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
09/15/2004EP1000932B1 Aromatic ring derivatives
09/15/2004EP0775689B9 Novel amine derivative, process for producing the same, and use thereof as antiarrhythmic
09/15/2004CN1529692A N-arylphenylacetamide derivatives and medicinal compositions containing same
09/15/2004CN1529591A Method for synthesizing phenol-containing compounds
09/15/2004CN1166622C 2-amino-1, 2-hydrindene as selective dopamine D3 ligands
09/15/2004CN1166403C Multicatalytic protease inhibitors
09/14/2004US6790991 Fomesafen produced by nitrating 3-(2-chloro-a,a,a-trifluoro-4-tolyloxy)-benzoic acid to form acifluorfen, converting to its acid chloride, and then reaction with methanesulfonamide
09/14/2004US6790990 Method for preparing fluorosulfonyl imide monomer
09/14/2004US6790989 Interleukin-1 beta converting enzyme/caspase; for prolonging viability of organs/cells for transplantation; for treating inflammatory, autoimmnune and neurodegenerative diseases; prevention of ischemic injury
09/14/2004US6790978 Thyromimetic organic compounds
09/14/2004US6790955 Reacting 2-sulfonamido, nitrobenzoic acid compound with in the presence of a halogenating agent, with formation of the carbonyl halide and its rearrangement; ammonolysis at so2cl group reducing at the nitro group; reacting with carbamate
09/14/2004US6790953 Ether compounds
09/14/2004US6790866 Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient
09/14/2004CA2103110C Insecticidal n'-substituted-n,n'-diacylhydrazines
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 177